Herriot Tabuteau

Insider Reports History

Entity
Individual
Signature
/s/ Herriot Tabuteau, M.D.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Herriot Tabuteau:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Axsome Therapeutics, Inc. Chief Executive Officer, Director, 10%+ Owner Performance Stock Units 28.6K $3.75M $131.07 Feb 24, 2025 Direct
Axsome Therapeutics, Inc. Chief Executive Officer, Director, 10%+ Owner Restricted Stock Units 28.6K $3.75M $131.07 Feb 21, 2025 Direct
Axsome Therapeutics, Inc. Chief Executive Officer, Director, 10%+ Owner Employee Stock Option (Right to Buy) 87.2K $305K $3.50 Feb 27, 2024 Direct
Axsome Therapeutics, Inc. Chief Executive Officer, Director, 10%+ Owner Employee Stock Option (Right to Buy) 28.9K Feb 21, 2025 Direct

Insider Reports Filed by Herriot Tabuteau

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AXSM Axsome Therapeutics, Inc. Feb 21, 2025 3 $0 4 Feb 25, 2025 Chief Executive Officer, Director, 10%+ Owner
AXSM Axsome Therapeutics, Inc. Feb 27, 2024 2 $0 4 Feb 29, 2024 CHIEF EXECUTIVE OFFICER, Director, 10%+ Owner
AXSM Axsome Therapeutics, Inc. Mar 2, 2023 2 $0 4 Mar 6, 2023 CHIEF EXECUTIVE OFFICER, Director, 10%+ Owner
AXSM Axsome Therapeutics, Inc. Mar 4, 2022 2 $0 4 Mar 8, 2022 CHIEF EXECUTIVE OFFICER, Director, 10%+ Owner